282 related articles for article (PubMed ID: 14633149)
1. Circulating level of alpha2-macroglobulin-beta2-microglobulin complex in hemodialysis patients.
Motomiya Y; Ando Y; Haraoka K; Sun X; Iwamoto H; Uchimura T; Maruyama I
Kidney Int; 2003 Dec; 64(6):2244-52. PubMed ID: 14633149
[TBL] [Abstract][Full Text] [Related]
2. Cartilage biomarkers in hemodialysis patients and the effect of beta2-microglobulin on articular chondrocytes.
Sunk IG; Demetriou D; Szendroedi J; Amoyo L; Raffetseder A; Hörl WH; Sunder-Plassmann G; Smolen JS; Bobacz K
Osteoarthritis Cartilage; 2008 Nov; 16(11):1336-42. PubMed ID: 18457963
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
[TBL] [Abstract][Full Text] [Related]
4. Serum beta2-microglobulin and immunoglobulin levels in young hemodialysis patients.
Dixit MP; Cabansag MR; Piscitelli J; Greifer I; Silverstein DM
Pediatr Nephrol; 1999 Feb; 13(2):139-42. PubMed ID: 10229003
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis.
Matsuo K; Ikizler TA; Hoover RL; Nakamoto M; Yasunaga C; Pupim LB; Hakim RM
Kidney Int; 2000 Feb; 57(2):697-708. PubMed ID: 10652049
[TBL] [Abstract][Full Text] [Related]
6. Hemodialysis-related amyloidosis: Is it still relevant?
Kaneko S; Yamagata K
Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815
[TBL] [Abstract][Full Text] [Related]
7. The relationship between pentosidine and hemodialysis-related connective tissue disorders.
Sakata S; Takahashi M; Kushida K; Oikawa M; Hoshino H; Denda M; Inoue T
Nephron; 1998; 78(3):260-5. PubMed ID: 9546683
[TBL] [Abstract][Full Text] [Related]
8. Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis.
Kazama JJ; Maruyama H; Gejyo F
Nephrol Dial Transplant; 2001; 16 Suppl 4():31-5. PubMed ID: 11402095
[TBL] [Abstract][Full Text] [Related]
9. Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis.
Giorgetti S; Stoppini M; Tennent GA; Relini A; Marchese L; Raimondi S; Monti M; Marini S; Østergaard O; Heegaard NH; Pucci P; Esposito G; Merlini G; Bellotti V
Protein Sci; 2007 Feb; 16(2):343-9. PubMed ID: 17242436
[TBL] [Abstract][Full Text] [Related]
10. Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010.
Hoshino J; Yamagata K; Nishi S; Nakai S; Masakane I; Iseki K; Tsubakihara Y
Nephrol Dial Transplant; 2016 Apr; 31(4):595-602. PubMed ID: 26206763
[TBL] [Abstract][Full Text] [Related]
11. Dialysis-related amyloidosis of the heart in long-term hemodialysis patients.
Takayama F; Miyazaki S; Morita T; Hirasawa Y; Niwa T
Kidney Int Suppl; 2001 Feb; 78():S172-6. PubMed ID: 11169005
[TBL] [Abstract][Full Text] [Related]
12. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis.
Jimenez RE; Price DA; Pinkus GS; Owen WF; Lazarus JM; Kay J; Turner JR
Am J Surg Pathol; 1998 Jun; 22(6):729-35. PubMed ID: 9630180
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry-based proteomic analysis of proteins adsorbed by hexadecyl-immobilized cellulose bead column for the treatment of dialysis-related amyloidosis.
Yamamoto S; Yamamoto K; Hirao Y; Yamaguchi K; Nakajima K; Sato M; Kawachi M; Domon M; Goto K; Omori K; Iino N; Shimada H; Aoyagi R; Ei I; Goto S; Goto Y; Gejyo F; Yamamoto T; Narita I
Amyloid; 2024 Jun; 31(2):105-115. PubMed ID: 38343068
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis of amyloidosis: a role for anti-proteases?].
Argilés i Ciscart A; Mourad G
Nephrologie; 1991; 12(2):51-4. PubMed ID: 1719439
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
Naganuma T; Sugimura K; Uchida J; Tashiro K; Yoshimura R; Takemoto Y; Nakatani T
Nephrology (Carlton); 2008 Apr; 13(2):104-8. PubMed ID: 18275497
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
Leypoldt JK
Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
[TBL] [Abstract][Full Text] [Related]
17. Glycosaminoglycans enhance the fibrillation propensity of the β2-microglobulin cleavage variant--ΔK58-β2m.
Corlin DB; Johnsen CK; Nissen MH; Heegaard NH
Biochem Biophys Res Commun; 2010 Nov; 402(2):247-51. PubMed ID: 20939999
[TBL] [Abstract][Full Text] [Related]
18. Impaired lysosomal processing of beta2-microglobulin by infiltrating macrophages in dialysis amyloidosis.
García-García M; Argilés ; Gouin-Charnet A; Durfort M; García-Valero J; Mourad G
Kidney Int; 1999 Mar; 55(3):899-906. PubMed ID: 10027926
[TBL] [Abstract][Full Text] [Related]
19. The relationship between concentrations of magnesium and oxidized low-density lipoprotein and Beta2-microglobulin in the serum of patients on the end-stage of renal disease.
Raikou VD; Kyriaki D
Saudi J Kidney Dis Transpl; 2016 May; 27(3):546-52. PubMed ID: 27215248
[TBL] [Abstract][Full Text] [Related]
20. Salivary beta2-microglobulin analysis in chronic kidney disease and hemodialyzed patients.
Michelis R; Sela S; Ben-Zvi I; Nagler RM
Blood Purif; 2007; 25(5-6):505-9. PubMed ID: 18187941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
